Yatrik M Shah

Yatrik M. Shah
Horace W Davenport Legacy Professor of Physiology
Professor of Molecular and Integrative Physiology
Professor of Internal Medicine and Associate Director Academic Programs
Cancer Biology Graduate Program
Medical School
[email protected]
Available to mentor
Yatrik M Shah
Yatrik M. Shah
Professor
  • About
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Shah received his PhD from the University of Toledo Health Science Center. After a postdoctoral fellowship at National Cancer Institute, he began his career as a principal investigator at the University of Michigan in 2010 in the Department of Molecular & Integrative Physiology and Internal Medicine, Division of Gastroenterology.

    Center Memberships

    • Center Member
      Center for Cell Plasticity and Organ Design
    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center

    Research Overview

    Our laboratory studies changes in oxygen, metabolic waste products and nutrients from both systemic and cellular perspectives in the GI tract. Our interests lie in understanding how these factors coordinate proliferation and cell death during development, maintain functional tissues/organs, and how dysregulation culminate in disease. Our goal is to provide fundamental insights into how oxygen, metabolic waste products and nutrients are integrated into tissue and cellular metabolic homeostasis, and to understand precise mechanisms by which cellular dysregulation of these pathways impacts anemia, hemochromatosis, inflammation and cancer.

    Recent Publications

    See All Publications
    • Journal Article
      Dysregulated Amino Acid Sensing Drives Colorectal Cancer Growth and Metabolic Reprogramming Leading to Chemoresistance
      Solanki S, Sanchez K, Ponnusamy V, Kota V, Bell HN, Cho CS, Kowalsky AH, Green M, Lee JH, Shah YM. Gastroenterology, 2023 Mar 1; 164 (3): 376 - 391.e13. DOI:10.1053/j.gastro.2022.11.014
      PMID: 36410445
    • Journal Article
      Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
      Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-derany MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, Kim D, Zhang L, Chen B, Mehra R, Frankel TL, Győrffy B, Fearon ER, Pasca di Magliano M, Gonzalez FJ, Banerjee R, Wahl DR, Lyssiotis CA, Green M, Shah YM. Cell Metabolism, 2023 Jan 3; 35 (1): 134 - 149.e6. DOI:10.1016/j.cmet.2022.11.013
      PMID: 36528023
    • Journal Article
      Modulation of the HIF2α-NCOA4 axis in enterocytes attenuates iron loading in a mouse model of hemochromatosis
      Das NK, Jain C, Sankar A, Schwartz AJ, Santana-Codina N, Solanki S, Zhang Z, Ma X, Parimi S, Rui L, Mancias JD, Shah YM. Blood, 2022 Apr 21; 139 (16): 2547 - 2552. DOI:10.1182/blood.2021013452
      PMID: 34990508
    • Journal Article
      Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
      Bell HN, Rebernick RJ, Goyert J, Singhal R, Kuljanin M, Kerk SA, Huang W, Das NK, Andren A, Solanki S, Miller SL, Todd PK, Fearon ER, Lyssiotis CA, Gygi SP, Mancias JD, Shah YM. Cancer Cell, 2021 Dec 1; 2021 Dec:
    • Journal Article
      Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells
      Schwartz AJ, Goyert JW, Solanki S, Kerk SA, Chen B, Castillo C, Hsu PP, Do BT, Singhal R, Dame MK, Lee HJ, Spence JR, Lakhal-Littleton S, Heiden MGV, Lyssiotis CA, Xue X, Shah YM. Nature Metabolism, 2023 Jul 10; 3 (7): 969 - 982. DOI:10.1038/s42255-021-00406-7
    • Journal Article
      HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
      Singhal R, Mitta SR, Das NK, Kerk SA, Sajjakulnukit P, Solanki S, Andren A, Kumar R, Olive KP, Banerjee R, Lyssiotis CA, Shah YM. Journal of Clinical Investigation, 2021 Jun 1; 131 (12): DOI:10.1172/JCI143691
      PMID: 33914705
    • Journal Article
      Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine
      Singhal R, Shah YM. Journal of Biological Chemistry, 2020 Jul 24; 295 (30): 10493 - 10505. DOI:10.1074/jbc.REV120.011188
      PMID: 32503843
    • Journal Article
      Myoglobin leaching into the serum of IDA mice is associated with elevated sGC activation under anemic conditions that correlates with increased myoglobin expression
      Ghosh A, Das NK, Sumi MP, Tupta B, Ghosh C, Stuehr DJ, Shah YM. Nitric Oxide Biology and Chemistry, 2026 Aug 1; 163: 1 - 8. DOI:10.1016/j.niox.2026.04.001

    Featured News & Stories

    close up microscopic grey close up
    Health Lab

    FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues

    University of Michigan researchers found that the FDA-approved drug fedratinib can lead to endoplasmic reticulum and mitochondria contact site formation, providing a potential therapeutic avenue.
    microscope drawing yellow navy
    Health Lab

    Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth

    University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.
    Research News

    Two U-M PhD students named to the HHMI Gilliam Fellows Program

    Two University of Michigan students and their PhD advisors have been named to the 2025 cohort of the HHMI Gilliam Fellows Program.
    pink cells up close
    Health Lab

    Research links iron-mediated cell death and inflammatory bowel disease

    New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.